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Schadenfreude –pleasure at others’ misfortunes– has been systematically related to ventral 
striatum activity. This brain region is affected early in individuals with manifest and pre-
manifest Huntington’s disease (HD). However, the experience of schadenfreude has not yet 
been investigated in HD. In this study, 21 manifest HD patients, 19 first-degree 
asymptomatic relatives, and 23 healthy controls performed an experimental task designed 
to trigger schadenfreude, envy (another social emotion acting as an affective control 
condition), and control situations. Both HD patients and first-degree relatives experienced 
lower schadenfreude in response to others’ misfortunes, with no group differences in 
ratings of envy and control conditions. These results offer unprecedented evidence of a 
highly specific impairment in reward processing, extending previous reports in manifest 
and pre-manifest HD individuals. Moreover, these findings suggest that early striatal 
impairments may be related to reduced feelings of schadenfreude. In sum, our work 
contributes to the understanding of emotional impairments in early stages of HD, while 
shedding light on their neural correlates. 
 




Schadenfreude refers to the perceiver’s experience of pleasure at another’s misfortune 
(Heider, 1958). This is a multidetermined emotion csidered harmful to social relations 
(Cikara & Fiske, 2013). Schadenfreude can be evoked by both hostile feelings and by envy 













latter emotion increases the probability of experienc ng schadenfreude (Cikara & Fiske, 
2013; Takahashi et al., 2009).  
 
At the neuroanatomical level, feelings of schadenfreude have been systematically related to 
ventral striatum activity (Cikara & Fiske, 2011; Cikara & Fiske, 2013; Takahashi et al., 
2009). This brain region is affected early in indivi uals with manifest (Mazziotta et al., 
1987; Nopoulos et al., 2010) and pre-manifest (Aylward et al., 1994; Weeks, Piccini, 
Harding, & Brooks, 1996; Weir, Sturrock, & Leavitt, 2011) Huntington’s disease (HD). 
HD is an autosomal dominant neurodegenerative disorer caused by an expanded CAG 
repeat on chromosome 4 (Conneally, 1984). This conditi  is classically characterized by 
cognitive, motor, and behavioral abnormalities associated with neuronal loss within 
corticostriatal circuits (Lawrence, Sahakian, & Robbins, 1998). Neuropathological and 
neuroimaging studies (Della Nave et al., 2010; Muhla  et al., 2007; Nopoulos et al., 2010) 
have revealed selective grey matter atrophy in HD, with the earliest changes progressing 
from the dorsolateral to the ventromedial portions f the neostriatum. At early stages, the 
cerebral cortex is selectively affected with early involvement of the operculum. 
Subsequently, progressive atrophy involves the insular, primary sensory, motor, and visual 
cortices, and then the primary auditory cortex. Finally, atrophy extends to the entorhinal 
cortex and higher order cortical regions. 
 
Importantly, structural and functional abnormalities n the basal ganglia (Hennenlotter et 
al., 2004; Ille et al., 2011; Kipps, Duggins, McCusker, & Calder, 2007) and frontostriatal 
pathways (Joel, 2001) have been associated with social cognition impairments in HD. 













in social cognitive domains (Hennenlotter et al., 2004). Moreover, social emotions, 
compared to basic emotions, provide a more ecological approach to investigate subtle 
impairments in psychiatric and neurological conditions (Baez, Garcia, & Ibanez, 2016; 
Baez et al., 2013; Baez & Ibanez, 2014; Baez et al., 2012; Ibanez & Manes, 2012).  To 
date, however, no previous work has assessed the role of ventral striatum alterations in 
schadenfreude. This study aims to bridge such gap. 
 
Schadenfreude is intimately related to reward mechanisms. Indeed, this emotion may 
involve heightened reward processing, which is supported by increased striatal engagement 
(Dvash, Gilam, Ben-Ze'ev, Hendler, & Shamay-Tsoory, 2010; Takahashi et al., 2009). In 
manifest and pre-manifest HD individuals (Enzi et al., 2012), impaired reward processing 
has been related to reduced activity of the ventral s iatum. Moreover, a decrease in the 
perceived pleasant or rewarding properties of events has been reported in animal models of 
HD (Renoir et al., 2011). Thus, given that reward processing and striatal regions are 
compromised early in this disease, subjects with manifest HD could be impaired in their 
capacity to experience schadenfreude. Moreover, the same could be expected in 
asymptomatic individuals with a family history of HD.  This population represents a 
vulnerability group with high probability of developing the disease or some unspecific 
related deficits (Panegyres & Goh, 2011). Crucially, as proposed by previous studies (Baez 
et al., 2015; Kargieman et al., 2014), vulnerability groups offer good clinical models to 
investigate the progress of HD and identify potential b omarkers. 
 
Against this background, we conducted an unprecedent  study on schadenfreude in 













we used a modified version of a previously reported experimental task (Takahashi et al., 
2009) in which unfortunate events happened to fictional individuals. Fortunate events were 
also included to generate envy, a social emotion related to schadenfreude (Takahashi et al., 
2009). Finally, neutral situations allowed testing task comprehension and attentional 
engagement. We hypothesized that both HD patients and relatives would experience lower 
levels of schadenfreude compared to healthy controls. Also, while schadenfreude is related 
to activity in the ventral striatum, envy is mainly mediated by the anterior cingulate and 
medial prefrontal cortices activity (Takahashi et al., 2009) –regions that are compromised 
later or even preserved in HD (Kassubek et al., 2004; Muhlau et al., 2007). Accordingly, 
we expected that the latter emotion would be preserv d in both HD patients and their 
relatives. 
 
2. Materials and methods 
2.1. Participants 
Sixty-three subjects participated in this study. The first group consisted of 21 patients 
genetically and clinically diagnosed with HD. A second group comprised 19 relatives 
(descendants or siblings) of those patients. They did not present any HD symptoms, and 
had not been diagnosed with HD or other neuropsychiatric diseases. Although relatives did 
not receive genetic testing, this population represents a vulnerability group (see details in 
Supplementary Data). Biological (Markianos, Panas, Kalfakis, & Vassilopoulos, 2008), 
clinical (Dorsey, 2012), and cognitive (Baez et al., 2015; Giordani et al., 1995; Kargieman 
et al., 2014) factors of familial vulnerability have been reported irrespective of whether the 
first-degree relatives are HD mutation carriers or n t. Assessing these individuals is 













Both groups underwent a neurological examination and were assessed using the Unified 
Huntington’s Disease Rating Scale (UHDRS)(Siesling, van Vugt, Zwinderman, Kieburtz, 
& Roos, 1998). In addition, HD patients were assessed with the Physical Disability Rating 
Scale (PDRS)(Myers et al., 1988) (Table 1). Patients a d relatives were recruited from 
Magdalena, Colombia, a region with a large concentration of individuals with HD (Baez et 
al., 2015; Kargieman et al., 2014). Patients and relativ s had no history of other major 
neurological illnesses, psychiatric disorders, or alcohol/drug abuse. 
 
The control group, recruited from the same region, c sisted of 23 healthy participants 
matched in age, gender, and years of education with the other two samples (Table 1). 
Control subjects did not have a history of alcohol/drug abuse, HD, or other neurologic or 
psychiatric disorders. All participants provided written informed consent in agreement with 
the Helsinki declaration. The Ethics Committee of the Autonomous Caribbean University 
approved the study.  
 
2.2. Instruments 
2.2.3. General cognitive state 
The participants’ general cognitive state was assessed with the Montreal Cognitive 
Assessment (MOCA) (Nasreddine et al., 2005). All participants were also evaluated with 
an EF battery which included the INECO frontal screening (IFS) (Torralva, Roca, 
Gleichgerrcht, Lopez, & Manes, 2009). The IFS has been shown to successfully detect 
executive dysfunction in patients with neurological and psychiatric diseases (Baez, Ibanez, 
et al., 2014; Torralva et al., 2009). This test includes the following eight subtests: (1) motor 













once when the administrator hits it twice, or hitting t twice when the administrator hits it 
only once); (3) motor inhibitory control; (4) numerical working memory (backward digit 
span); (5) verbal working memory (months backwards); (6) spatial working memory 
(modified Corsi tapping test); (7) abstraction capacity (inferring the meaning of proverbs), 
and (8) verbal inhibitory control (modified Hayling test). The maximum possible score on 
the IFS is 30 points. 
 
2.2.1. Experimental task 
Based on an existing protocol (Takahashi et al., 2009), we designed an experimental task to 
assess levels of schadenfreude and envy. On account of the cognitive state of the HD 
patients, the original task was modified and the characteristics of the target person (i.e., 
levels of possession and self-relevance of comparison domains) were not considered in our 
design. In the experimental task each participant was shown a real-life photograph and a 
description of two target characters matched in age and gender with the participant –
relevant data were obtained in a brief interview before the task.  
 
The task comprised two experimental blocks. In the first block, participants read eight 
sentences describing fortunate events (e.g., winning the lottery) involving either character 
(four events per character). After reading each sentence, participants rated the event in 
terms of how much envy they felt for the character (1 = no envy, 9 = extreme envy). In the 
second block, participants read and reported the intensity of their pleasure (schadenfreude, 
1 = no pleasure, 9 = extreme pleasure) in response t  eight unfortunate events (e.g., 
cuckoldry caused by the character’s girlfriend/boyfriend) happening to the characters (four 













each block. Events were presented in pseudo-randomized order. They were selected from 
an initial survey conducted to validate our materials (see Supplementary Data). Results of 
the pilot study showed that ratings for sentences describing fortunate and unfortunate 
events were significantly different from those for neutral sentences. Mean values of the 
ratings of envy and schadenfreude were 3.72 (SD = 1.81) and 4.4 (SD = 2.18), respectively. 
The mean rating for neutral events was 1.29 (SD = 0.68). 
 
2.3. Data analysis 
Demographic and cognitive state data were compared among groups using ANOVA and 
Tukey’s HSD post-hoc tests. Chi square tests were applied to analyze categorical variables 
(gender). Ratings of schadenfreude and envy were analyzed via one-way ANOVAs. 
Tukey’s HSD post-hoc tests were used when appropriate. To control for the influence of 
general cognitive status on the experimental task, we applied ANCOVA tests adjusted 
independently for MOCA and IFS total scores. As in other reports of neurodegenerative 
conditions of our group (Baez, Kanske, et al., 2016; Baez, Manes, et al., 2014; Baez, 
Morales, et al., 2016; Sedeño et al., 2016), only those effects that remained significant after 
covariation are reported. Moreover, in order to explore the relationship between executive 
functions, envy, and schadenfreude, we performed correlation analyses between global IFS 
scores and social emotion ratings for each group independently. Effect sizes were 
calculated through partial eta squared (η2).  
 
3. Results 













Significant differences among groups were observed in the total MOCA score 
(F(2,61)=17.60, p<0.01, η2=0.36). A post-hoc analysis (Tukey’s HSD, MS=21.14, df=61) 
revealed that HD patients were outperformed by relatives (p<0.01) and controls (p<0.01). 
Significant differences among groups were also observed on the total IFS score 
(F(2,61)=35.01, p<0.01, η2=0.53). A post-hoc analysis (Tukey’s HSD, MS=12.39, df=61) 
showed that HD patients had a poorer performance than relatives (p<0.01) and controls 
(p<0.01). A detailed analysis of scores in the IFS subscales revealed that HD patients were 
outperformed by controls in all executive measures, while relatives showed lower scores 
than controls only in the backward digit span task (see Table 1).  
 
3.2. Schadenfreude and envy 
For HD patients, the mean value of envy ratings was 3.8 (SD = 2.0) and the mean value of 
schadenfreude ratings was 3.3 (SD = 1.2). For relatives, the mean values of envy and 
schadenfreude ratings were 3.6 (SD = 2.1) and 3.1 (SD = 1.9) respectively. For controls, the 
mean of envy ratings was 3.0 (SD = 2.9) and the mean of schadenfreude ratings was 5.4 
(SD = 2.0). 
 
No differences among groups were observed in ratings of envy (F(2,61)=1.57, p=0.21, 
η2=0.04) or ratings for neutral situations (F(2,61)=1.49, p=0.23, η2=0.04). However, there 
were significant differences in schadenfreude ratings (F(2,61)=21.30, p<0.001, η2=0.41). A 
post-hoc analysis (Tukey’s HSD, MS=2.88, df=61) revealed that HD patients (p<0.001) 
and relatives (p<0.001) showed lower schadenfreude ratings than controls. No significant 














Correlation analyses between envy ratings and global IFS scores showed no significant 
associations in any group (HD patients: r = -0.31, p = 0.16; relatives: r = -0.39, p = 0.09; 
controls: r = 0.27, p = 0.18). Neither schadenfreude ratings correlated with global IFS 
scores in any group (HD patients: r = -0.09, p = 0.67; relatives: r = -0.36, p = 0.12; 
controls: r = 0.15, p = 0.47). 
 
4. Discussion 
This is the first study investigating schadenfreude and envy in HD patients and their first-
degree relatives. As expected, we found that schadenfreude was selectively reduced in both 
HD patients and relatives, while envy remained unimpaired. Our results illuminate social 
emotion impairments in HD and may have important cli ical implications. 
 
4.1. Schadenfreude and envy 
Compared to controls, both HD patients and first-degre  relatives exhibited lower 
schadenfreude in response to others’ misfortunes. Thi  could reflect well-established 
impairments in reward processing, shared by individuals with manifest and pre-manifest 
HD (Enzi et al., 2012). In the same vein, animal models (Renoir et al., 2011) have shown 
that HD mice exhibit reduced reactivity to reward, as evidenced by a decreased preference 
for saccharin solutions. Schadenfreude represents a rewarding feeling derived from 
another’s misfortune. Evidence of activations of reward system areas (Cikara & Fiske, 
2013; Takahashi et al., 2009) (i.e., the ventral striatum) during schadenfreude further 
reinforces the rewarding nature of this emotion.  
 













al., 1987; Nopoulos et al., 2010) and pre-manifest (Aylward et al., 1994; Weeks, Piccini, 
Harding, & Brooks, 1996; Weir, Sturrock, & Leavitt, 2011) HD. Our findings suggest that 
a highly specific social emotion impairment in those populations could be directly linked to 
reward system impairments following early damage to the ventral striatum. Previous 
studies suggest that basal ganglia abnormalities in HD are associated with multiple 
impairments, including motor (Thompson et al., 1988), linguistic (Kargieman et al., 2014; 
Longworth, Keenan, Barker, Marslen-Wilson, & Tyler, 2005), socio-cognitive (Aviezer et 
al., 2009; Baez et al., 2015), and other high-order (Lawrence et al., 1996) deficits. Our 
results suggest that striatal abnormalities observed in HD patients and first-degree relatives 
may also affect the experience of schadenfreude. Moreover, degeneration of direct and 
indirect pathways arising from the striatum leads to impaired functioning of motor, 
cognitive, and affective circuits (Joel, 2001) in HD patients. Thus, abnormal schadenfreude 
may be better understood in terms of cortico-striatal network disruptions. Increasing 
evidence (e.g., Unschuld et al., 2012; Wolf et al., 2008) shows that cognitive and affective 
deficits in HD involve abnormal connectivity between the basal ganglia and cortical hubs. 
Further studies should explore the relationship betwe n functional connectivity within 
cortico-striatal networks and the experience of schadenfreude in HD patients and 
asymptomatic first-degree relatives. 
 
In addition, the experience of schadenfreude implies various mechanisms and may be 
associated to diverse cognitive processes impaired in HD. For instance, executive functions 
are required to properly perform tasks tapping emotional and social cognition domains 
(Pessoa, 2008; Uekermann et al., 2010). Emotional processing requires holding stimulus-













executive processes may be affected in HD patients (Lawrence et al., 1996) and 
asymptomatic carriers (Verny et al., 2007). However, ou  results showed that reduced 
schadenfreude is not related to executive dysfunctio . Future studies should further assess 
the relationship between executive functions and social emotions in HD. Schadenfreude 
may also be linked to counterfactual thinking –generating thoughts about alternatives to 
past events, actions and outcomes (Bault, Coricelli, & Rustichini, 2008). Social emotions, 
such as schadenfreude and envy, may involve reflecting on decisions that we could have 
made and chose not to make, but which were adopted by someone else, thereby providing 
information on the outcome of choices of the other person (Coricelli & Rustichini, 2010; 
van de Ven & Zeelenberg, 2015). Counterfactual thinking is also impaired in HD patients 
(Solca et al., 2015), which may be related to the reduction of schadenfreude reported 
herein. Further experimental studies are needed to understand the specific relationship 
between schadenfreude and counterfactual cognition in manifest and pre-manifest HD 
patients.  
Ratings of envy were similar among HD patients, relatives, and controls. This aligns with 
evidence that envy critically involves activations over ventral prefrontal areas, in particular 
the anterior cingulate cortex (Dvash et al., 2010; Takahashi et al., 2009). Neuroimaging 
studies have shown that gray matter in these areas is preserved in HD patients (Kassubek et 
al., 2004; Muhlau et al., 2007). Furthermore, contrary to schadenfreude, envy is an 
unrewarding emotion that involves feelings of discontent in the face of another person’s 
good fortune. The differential pattern we observed arguably reflects the distinct nature and 
neural basis of schadenfreude relative to envy. The preservation of this closely related 
emotion support the distinctiveness of schadenfreude impairments following early brain 














Future studies should confirm and extend these unprecedented findings. As in other reports 
including vulnerable HD populations (Baez et al., 2015; Kargieman et al., 2014), the 
relatives assessed here did not receive genetic testing. Thus, the sample may have included 
both genetic pre-symptomatic individuals and healthy relatives without genetic HD 
heredity. Nevertheless, note that biological (Markinos et al., 2008), clinical (Dorsey, 2012; 
Robins Wahlin et al., 2000), and cognitive (Giordani et al., 1995; Kargieman et al., 2014) 
factors of familial vulnerability have been reported irrespective of whether the first-degree 
relatives were HD mutation carriers or not. For insta ce, healthy individuals at risk for HD 
(Giordani et al., 1995), regardless of their HD gene status, may exhibit low performance in 
some neuropsychological measures. Consistent with recent studies (Baez et al., 2015; 
Kargieman et al., 2014), our results showed that although the relatives group assessed here 
might include both HD gene carriers and non-carriers, its performance on social emotion 
tasks was significantly different from that of controls. Thus, they can reasonably be framed 
as a vulnerability group at risk of developing HD. Assessing these individuals is important 
to understand the nature of HD and identify potential b omarkers. Future studies should 
further assess social emotions in first-degree relativ s with and without the HD mutation. 
 
The selective reduction of schadenfreude in HD patients and relatives may conceivably be 
related to a general impairment in reward processing (E zi et al., 2012). As we did not 
include a more general measure of this domain, future investigations in HD should aim to 
disentangle the relative contribution of specific vs. global impairments in reward 
processing. Furthermore, considering that such general impairments in HD may impact on 













anhedonia symptoms) cognitive and affective domains, further studies should adopt a 
multidimensional approach to understand such alterations. In addition, further research 
should employ structural and functional neuroimaging methods to explore brain 
abnormalities in HD patients or relatives, and their r lationship with reward processing. 
Further volumetric and fMRI studies may provide additional insights about the specific 
relationship among structural and functional changes in the ventral striatum and associated 
schadenfreude deficits.  
 
Our findings may also have important clinical implications. Social emotions such as 
schadenfreude and envy have not been previously studied in HD. The present findings 
suggest that processing of social emotions may be included in the clinical assessment of 
HD patients or asymptomatic relatives. Given that facial emotion recognition has been 
proposed as a sensitive marker of disease onset and progression in HD (e.g., Paulsen et al., 
2006; Tabrizi et al., 2009), our results suggest that processing of social emotions may also 
constitute a potential marker of HD onset or vulnerability. Large-scale longitudinal studies 
are required to test this possibility. Moreover, our results indicate the existence of a 
possible link between the diminished capacity to experience schadenfreude and reward 
processing, which are probably related to relevant cli ical symptoms of HD (i.e., 
anhedonia). Reward processing impairments may be a dimensional symptom underlying 
various clinical features of HD. For instance, reward may be related to both anhedonia and 
specific social cognition impairments, as well as social disinterest and lack of pleasure from 
social contact. Future studies should explore the specific relationship between reward, 
















The findings of this exploratory study showed that t e malicious pleasure of schadenfreude 
is selectively reduced in HD patients and asymptomaic first-degree relatives, opening a 
new field of research regarding reward processing, social emotions, and neurodegeneration. 
Our findings open the door to future studies investigating social emotion processing in 
other clinical populations characterized by striatal impairments (e.g., Parkinson’s disease 
and schizophrenia). This particular knowledge might have important implications for 
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Figure Legend 
Figure 1. Schadenfreude and envy ratings. HD patients and relatives showed lower 
schadenfreude ratings than controls. No differences were observed in envy or neutral 
ratings. Boxes represent median and interquartile range values, and whiskers indicate the 













Table 1. Demographic, clinical and executive functions assessments.  

















Demographics Age (years) 45.0 (10.1) 37.7 (17.2) 40.0 (14.7) NS NS 
Gender (F:M) 12:9 12:7 12:12 NS NS 
Education (years)   7.0 (2.3) 6.5 (2.2) 6.1 (2.7) NS NS 
Clinical assessment UHDRS 22.0 (9.6) 1.8 (2.2)    
PDRS 73.8 (14.9) 99.4 (2.2)    
Cognitive assessment MOCA total score 15.7 (5.9) 23.6 (3.7) 22.2 (3.8) 0.0001 NS 
IFS Total Score 14.5 (5.1) 20.1 (2.8) 22.0 (1.9) 0.001 NS 
Motor series 1.9 (0.7) 2.7 (0.5) 2.8 (0.4) 0.0002 NS 
Conflicting instructions 1.5 (0.8) 2.8 (0.3) 2.7 (0.4) 0.0001 NS 
Go- no go 0.9 (0.7) 2.0 (0.7) 2.3 (0.5) 0.0001 NS 
Backward digits span 2.0 (0.9) 2.8 (0.9) 3.5 (0.5) 0.0001 0.02 
Verbal Working memory 0.9 (0.5) 1.3 (0.4) 1.5 (0.5) 0.0004 NS 
Spatial working memory 1.6 (0.9) 2.4 (0.6) 2.3 (0.4) 0.001 NS 
Abstraction capacity 1.4 (0.9) 2.0 (0.8) 2.5 (0.6) 0.0002 NS 
Verbal inhibitory control 2.7 (1.3) 3.7 (0.9) 4.0 (.9) 0.0004 NS 
HD=Huntington's disease patients; REL=Asymptomatic relatives; UHDRS=Unified 
Huntington’s Disease Rating Scale; PDRS=Physical Disability Rating Scale total functional 
capacity scale; MOCA=Montreal Cognitive Assessment; IFS=INECO frontal screening. 
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